Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death
- PMID: 27166248
- DOI: 10.1161/CIRCHEARTFAILURE.115.002896
Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death
Abstract
Background: Management of hemolysis in the setting of suspected device thrombosis in continuous-flow left ventricular assist device patients varies widely, ranging from watchful waiting with intensified antithrombotic therapy to early surgical device exchange. The aim of this study was to compare the outcomes of hemolysis events treated with surgical interventions versus medical management alone.
Methods and results: A retrospective review of Heartmate II continuous-flow left ventricular assist device patients at 2 centers from January 2009 to September 2014 was completed. Patients were categorized as surgical management if hemolysis refractory to intensification of standard antithrombotic therapy was treated surgically. The primary end point was the first occurrence of cerebrovascular accident (CVA) or death. Sixty-four hemolysis events occurred in 49/367 patients implanted with Heartmate II continuous-flow left ventricular assist devices. Of 49 primary hemolysis events, 24 were treated with surgical interventions. After surgical treatment, 1 patient died and 2 experienced CVAs, as compared with 3 deaths and 9 CVAs in the 25 patients who remained on intensified antithrombotic therapy alone. The 1-year freedom from CVA or death was 87.5% and 49.5% in the surgical and medical cohorts, respectively (P=0.027). Resolution of a primary hemolysis event without CVA or death occurred in 21/24 patients treated with surgical interventions and in 13/25 who remained on medical therapy alone. A similar association between treatment and outcome was noted in the 15 recurrent hemolysis events.
Conclusions: Hemolysis refractory to intensification of antithrombotic therapy identifies continuous-flow left ventricular assist device patients at major risk for CVA and death. Early device exchange should be considered to minimize these risks.
Keywords: analysis; heart failure; hemolysis; hemorrhage; thrombosis.
© 2016 American Heart Association, Inc.
Comment in
-
Operating in the Dark: When Is Surgery Necessary for Left Ventricular Assist Device Hemolysis?Circ Heart Fail. 2016 May;9(5):e003141. doi: 10.1161/CIRCHEARTFAILURE.116.003141. Circ Heart Fail. 2016. PMID: 27166249 No abstract available.
Similar articles
-
Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.J Thorac Cardiovasc Surg. 2013 Aug;146(2):437-41.e1. doi: 10.1016/j.jtcvs.2013.02.018. Epub 2013 Mar 13. J Thorac Cardiovasc Surg. 2013. PMID: 23490245
-
Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.Artif Organs. 2013 Mar;37(3):313-8. doi: 10.1111/j.1525-1594.2012.01567.x. Epub 2013 Feb 4. Artif Organs. 2013. PMID: 23373528
-
Long-term discontinuation of antithrombotic therapy in patients with HeartMate II continuous-flow left ventricular assist device support.Int J Artif Organs. 2019 Dec;42(12):770-774. doi: 10.1177/0391398819861976. Epub 2019 Jul 12. Int J Artif Organs. 2019. PMID: 31298625
-
Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.ASAIO J. 2014 May-Jun;60(3):361-5. doi: 10.1097/MAT.0000000000000067. ASAIO J. 2014. PMID: 24614354 Review.
-
What is the optimal anticoagulation in patients with a left ventricular assist device?Interact Cardiovasc Thorac Surg. 2012 Oct;15(4):733-40. doi: 10.1093/icvts/ivs297. Epub 2012 Jul 3. Interact Cardiovasc Thorac Surg. 2012. PMID: 22761118 Free PMC article. Review.
Cited by
-
Cardiac prostheses-related hemolytic anemia.Clin Cardiol. 2019 Jul;42(7):692-700. doi: 10.1002/clc.23191. Epub 2019 May 6. Clin Cardiol. 2019. PMID: 31039274 Free PMC article. Review.
-
A subcostal approach is favorable compared to sternotomy for left ventricular assist device exchange field of research: artificial heart (clinical).J Artif Organs. 2019 Sep;22(3):181-187. doi: 10.1007/s10047-019-01102-w. Epub 2019 Apr 11. J Artif Organs. 2019. PMID: 30976935
-
Outcomes following left ventricular assist device exchange.J Card Surg. 2020 Mar;35(3):591-597. doi: 10.1111/jocs.14423. Epub 2020 Jan 16. J Card Surg. 2020. PMID: 31945223 Free PMC article.
-
Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.ESC Heart Fail. 2019 Oct;6(5):1005-1014. doi: 10.1002/ehf2.12473. Epub 2019 Jul 18. ESC Heart Fail. 2019. PMID: 31318170 Free PMC article.
-
Hemostatic complications associated with ventricular assist devices.Res Pract Thromb Haemost. 2019 Jun 9;3(4):589-598. doi: 10.1002/rth2.12226. eCollection 2019 Oct. Res Pract Thromb Haemost. 2019. PMID: 31624778 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical